We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cardiovascular disease in the literature: a selection of recent original research papers.
- Authors
Hage, Fadi G.; AlJaroudi, Wael
- Abstract
B I Significance: i b In patients for whom statin medications are indicated to lower cardiovascular risk but who are unable or unwilling to take statins at appropriate doses, bempedoic acid lowers LDL and CRP levels and lowers the risk of cardiovascular events. B Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients. b B I NEJM i b B . doi: b 10.1056/NEJMoa2215024 B . b B I Background: i b Bempedoic acid is an ATP citrate lyase inhibitor that targets cholesterol synthesis upstream of statin drugs. It would be interesting to assess whether patients who achieved the LDL goal of 50-70 mg/dl on medium dose statin had similar benefit compared to those who achieved LDL < 70 md/dl using high-intensity statin.
- Subjects
HEART failure; CARDIOVASCULAR diseases; DIASTOLIC blood pressure; SYSTOLIC blood pressure
- Publication
Journal of Nuclear Cardiology, 2023, Vol 30, Issue 3, p915
- ISSN
1071-3581
- Publication type
Article
- DOI
10.1007/s12350-023-03275-7